Diseases and disorders

Physicians and biologists here present their experimental work in the field of hyperthermia, paying particular regard to its relevance in clinical situations.

Physicians, biologists and physicists present their recent work in the field of hyperthermia with regard to both its application and its combination with radiation and chemotherapy.

Minimal neoplasia may be defined as a small cancer that has progressed beyond its site of primary origin into the surrounding tissue, but that has not yet reached the stage of deeper invasion or metastasization.

This series on the treatment of cancer is sponsored by the UICC.

Seit der 1.

A number of clinical and epidemiological studies have shown that disorders of lipoprotein metabolism constitute one of the most important risk factors for the development of atherosclerosis and coronary heart disease.

Primary malignant tumors of the gastrointestinal tract account for 23% of all invasive cancers and 24% of all the deaths in 1988.

The preceding decade has seen the production of many cancer at- lases.

Initiated in 1975, the Eberbach/Wiesloch Study is a prospective preventive study modeled after the Cardiovascular Comprehensive Community Central Programme of the WHO, with the aim of lowering the incidence of cardiac infarctions in a population representative of that of the Federal Republic of Germany.

The contemporary management of patients with cancers of the head and neck is under careful scrutiny and major changes are being introduced in order to improve the potenti- al not only for long-term control but also for less in the way of disfiguring and distres- sing complications associated with the treatment programs.

On November 6 and 7, 1987, lipid and lipoprotein researchers from all over Europe convened in Munich on the occasion of the second European Workshop on Lipid Metabolism (EWLM).

This series on the treatment of cancer is sponsored by the UICe.

Modem Methods of Plant Analysis When the handbook Modern Methods of Plant Analysis was fIrst introduced in 1954 the considerations were: 1.

The symposium on supportive care in cancer patients, which took place in St.

The Third International Copenhagen Symposium on Detection of Breast Cancer afforded a further opportunity for scientists from all over the world to come together and present important papers con- cerning breast cancer and early diagnostic procedures.

The series "e;Medical Radiology - Diagnostic Imaging and Radiation Oncology"e; is the successor to the well known "e;Encyclopedia of Medical RadiologyjHandbuch der medizinischen Radiologie"e;.

This new series on the treatment of cancer is sponsored by the VICe.

Despite recent advances in adjuvant therapies of cancer, the regi- mens of postoperative adjuvant chemotherapy treatment which are presently available fail to cure the majority of cancer patients.

Interest in the etiology of malignant melanoma has increased enor- mously in the last 10 years, after it was realized that the incidence of the cutaneous form of the disease was rising.

Primary and metastasizing malignant carcinoma of the liv- er represent a challenge to both the diagnostician and the therapist.

The incidence of lung cancer has reached epidemic proportions throughout the civilized world.

The present challenge in the treatment of tumors is to reduce the number of patients that still die as a result of primary tumors.

Das Buch führt ein in die Grundlagen der Immunologie, der Pathologie und der Pharmako-Therapie rheumatologischer Krankheiten.

It is a very special honour for me to be able to present this handbook of medical oncology, which under diverse headings and origins covers such a vast spectrum of experience.

One reason for failure to cure solid tumors by surgery appears to be the impossibility of controlling metastases that are present but latent at the time of operation.

H.

Malignant growth of cells is often characterized by disorganization of tissue structure, abnormal blood vessel development, and insuffi- cient vascular supply.

Predictive drug testing on human tumor cells in order to define the appropriate chemotherapy will remain imperative as long as the anticancer agents available are few in number and show only limited activity.

Much of the attention presently paid to leukemia is the result of recent progress in understanding and treatment.

At first glance it appears that little has happened in our understanding of bronchogenic carcinoma, since five year survival rates have not changed appreciably over the past ten years.

Each year a multidisciplinary symposium on Clinical Oncology is organised by the Royal College of Radiologists in London.

Several papers dealing with the clinical relevance of steroid hormone receptors in breast cancer have already been published.

The life of a human being is finite, and all humans age (see Fries 1980).

This publication brings together a number of papers presented at the Fourth Symposium on Clinical Oncology held at the Royal College of Radiologists, London, in February 1982.

The enormous expansion seen over the last decade in the mammo- graphic detection of breast cancer lesions, especially the use of screen- ing procedures for the early detection of clinically unsuspected tumors, has made it necessary to summarize the experience made by various centers in the world.

Pain is unfortunately not an early symptom in neoplastic diseases.

Substantial relief of discomfort may be anticipated by most patients suffering from pelvic and lower-extremity pain who are treated by arterial infusion of nitrogen mustard.

Since cytotoxic drugs were first developed, their damaging effects on bone marrow have attracted considerable interest.

Transplantation of syngeneic (donor is a monozygous twin) or allogeneic (donor is an HLA-identical sibling) marrow provides the opportunity for aggressive antileukemic therapy without regard to marrow toxicity.

Attempts to influence survival of patients with colorectal cancer (CRC) by adjuvant chemotherapy are limited by the variability of survival in different prognostic groups [4] and the paucity of drugs that have shown activity in the advanced disease [10].

The purpose of this monograph is to address the basic mecha- nisms for organizing trials.

In February 1980 the Royal College of Radiologists, London, held its Second Symposium on Clinical Oncology.